Propofol inhibits high glucose-induced PP2A expression in human umbilical vein endothelial cells

Vascular Pharmacology

Volumn 91, Issue , 2017, Pages 18-25

  Wu, Qichao ^a   Zhao, Yanjun ^a,b   Duan, Wenming ^c   Liu, Yi ^a,b   Chen, Xiangyuan ^a   Zhu, Minmin ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

CaMK II; CREB; High glucose; PP2A

Indexed keywords

BETA ACTIN; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIZOCILPINE; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PHOSPHATASE; PHOSPHATASE A2; PROPOFOL; RAPASTINEL; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CREB1 PROTEIN, HUMAN; INTRAVENOUS ANESTHETIC AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; PHOSPHOPROTEIN PHOSPHATASE 2; SUPEROXIDE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; TIME FACTOR;

ANESTHETICS, INTRAVENOUS; ANTI-INFLAMMATORY AGENTS; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NITRIC OXIDE; PHOSPHORYLATION; PROPOFOL; PROTEIN PHOSPHATASE 2; RECEPTORS, N-METHYL-D-ASPARTATE; SUPEROXIDES; TIME FACTORS;

EID: 85012022772     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2017.02.002     Document Type: Article

References (34)

1. Werb, M.R., Zinman, B., Teasdale, S.J., Goldman, B.S., Scully, H.E., Marliss, E.B., Hormonal and metabolic responses during coronary artery bypass surgery: role of infused glucose. J. Clin. Endocrinol. Metab. 69 (1989), 1010–1018.
2. Walts, L.F., Miller, J., Davidson, M.B., Brown, J., Perioperative management of diabetes mellitus. Anesthesiology 55 (1981), 104–109.
3. Cai, S., Khoo, J., Channon, K.M., Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovasc. Res. 65 (2005), 823–831.
4. van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., Bouillon, R., Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 345 (2001), 1359–1367.
5. Furnary, A.P., Gao, G., Grunkemeier, G.L., Wu, Y., Zerr, K.J., Bookin, S.O., Floten, H.S., Starr, A., Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 125 (2003), 1007–1021.
6. Krinsley, J.S., Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin. Proc. 79 (2004), 992–1000.
7. Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P.J., Milants, I., Van Wijngaerden, E., Bobbaers, H., Bouillon, R., Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 354 (2006), 449–461.
8. Paneni, F., Mocharla, P., Akhmedov, A., Costantino, S., Osto, E., Volpe, M., Lüscher, T.F., Cosentino, F., Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes. Circ. Res. 111 (2012), 278–289.
9. Cosentino, F., Francia, P., Camici, G.G., Pelicci, P.G., Lüscher, T.F., Volpe, M., Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. Arterioscler. Thromb. Vasc. Biol. 28 (2008), 622–628.
10. Sun, L., Xiao, L., Nie, J., Liu, F.Y., Ling, G.H., Zhu, X.J., Tang, W.B., Chen, W.C., Xia, Y.C., Zhan, M., Ma, M.M., Peng, Y.M., Liu, H., Liu, Y.H., Kanwar, Y.S., p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway. Am. J. Physiol. Ren. Physiol. 299 (2010), 1014–1025.
11. Diogo, C.V., Suski, J.M., Lebiedzinska, M., Karkucinska-Wieckowska, A., Wojtala, A., Pronicki, M., Duszynski, J., Pinton, P., Portincasa, P., Oliveira, P.J., Wieckowski, M.R., Cardiac mitochondrial dysfunction during hyperglycemia-the role of oxidative stress and p66Shc signaling. Int. J. Biochem. Cell Biol. 45 (2013), 114–122.
12. Zhu, M., Chen, J., Tan, Z., Wang, J., Propofol protects against high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells. Anesth. Analg. 114 (2012), 303–309.
13. Zhu, M., Chen, J., Jiang, H., Miao, C., Propofol protects against high glucose-induced endothelial adhesion molecules expression in human umbilical vein endothelial cells. Cardiovasc. Diabetol., 12, 2013, 13.
14. Zhu, M., Wen, M., Sun, X., Chen, W., Chen, J., Miao, C., Propofol protects against high glucose-induced endothelial apoptosis and dysfunction in human umbilical vein endothelial cells. Anesth. Analg. 120 (2015), 781–789.
15. Wang, J., Jiang, H., Wang, J., Zhao, Y., Zhu, Y., Zhu, M., Propofol attenuates high glucose-induced superoxide anion accumulation in human umbilical vein endothelial cells. Fundam. Clin. Pharmacol. 30 (2016), 511–516.
16. Mathy-Hartert, M., Deby-Dupont, G., Hans, P., Deby, C., Lamy, M., Protective activity of propofol, Diprivan and intralipid against active oxygen species. Mediat. Inflamm. 7 (1998), 327–333.
17. Zhu, M., Chen, J., Wen, M., Sun, Z., Sun, X., Wang, J., Miao, C., Propofol protects against angiotensin II-induced mouse hippocampal HT22 cells apoptosis via inhibition of p66Shc mitochondrial translocation. Neuromolecular. Med. 16 (2014), 772–781.
18. Bonati, A., Carlo-Stella, C., Lunghi, P., Albertini, R., Pinelli, S., Migliaccio, E., Sammarelli, G., Savoldo, B., Tabilio, A., Dall'Aglio, P.P., Pelicci, P.G., Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34 + fraction of chronic myelogenous leukemias. Cancer Res. 60 (2000), 728–732.
19. Migliaccio, E., Giorgio, M., Pelicci, P.G., Apoptosis and aging: role of p66Shc redox protein. Antioxid. Redox Signal. 8 (2006), 600–608.
20. Paneni, F., Volpe, M., Lüscher, T.F., Cosentino, F., SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together. Diabetes 62 (2013), 1800–1807.
21. Tsai, H.H., Lee, W.R., Wang, P.H., Cheng, K.T., Chen, Y.C., Shen, S.C., Propionibacterium acnes-induced iNOS and COX-2 protein expression via ROS-dependent NF-kappaB and AP-1 activation in macrophages. J. Dermatol. Sci. 69 (2013), 122–131.
22. Simard, J.C., Cesaro, A., Chapeton-Montes, J., Tardif, M., Antoine, F., Girard, D., Tessier, P.A., S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-kappaB. PLoS One, 8, 2013, e72138.
23. Yasuoka, C., Ihara, Y., Ikeda, S., Miyahara, Y., Kondo, T., Kohno, S., Antiapoptotic activity of Akt is down-regulated by Ca2 + in myocardiac H9c2 cells. Evidence of Ca(2 +)-dependent regulation of protein phosphatase 2Ac. J. Biol. Chem. 279 (2004), 51182–51192.
24. Wu, X., McMurray, C.T., Calmodulin kinase II attenuation of gene transcription by preventing cAMP response element-binding protein (CREB) dimerization and binding of the CREB-binding protein. J. Biol. Chem. 276 (2001), 1735–1741.
25. Kornhauser, J.M., Cowan, C.W., Shaywitz, A.J., Dolmetsch, R.E., Griffith, E.C., Hu, L.S., Haddad, C., Xia, Z., Greenberg, M.E., CREB transcriptional activity in neurons is regulated by multiple, calcium-specific phosphorylation events. Neuron 34 (2002), 221–233.
26. Paltauf-Doburzynska, J1., Malli, R., Graier, W.F., Hyperglycemic conditions affect shape and Ca2 + homeostasis of mitochondria inendothelial cells. J. Cardiovasc. Pharmacol. 44 (2004), 423–436.
27. Mohammadi, B., Haeseler, G., Leuwer, M., Dengler, R., Krampfl, K., Bufler, J., Structural requirements of phenol derivatives for direct activation of chloride currents via GABAA receptors. Eur. J. Pharmacol. 421 (2001), 85–91.
28. Reiner, G.N., Perillo, M.A., García, D.A., Effects of propofol and other GABAergic phenols on membrane molecular organization. Colloids Surf. B: Biointerfaces 101 (2013), 61–67.
29. Irifune, M., Takarada, T., Shimizu, Y., Endo, C., Katayama, S., Dohi, T., Kawahara, M., Propofol-induced anesthesia in mice is mediated by γ-aminobutyric acid-A and excitatory amino acid receptors. Anesth. Analg. 97 (2003), 424–429.
30. Kundu, S., Pushpakumar, S.B., Tyagi, A., Coley, D., Sen, U., Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9. Am. J. Physiol. Endocrinol. Metab. 304 (2013), E1365–E1378.
31. MacDermott, A.B., Mayer, M.L., Westbrook, G.L., Smith, S.J., Barker, J.L., NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature 321 (1986), 519–522.
32. Mayer, M.L., Westbrook, G.L., The physiology of excitatory amino acids in the vertebrate central nervous system. Prog. Neurobiol. 28 (1987), 197–276.
33. Wahl, P., Schousboe, A., Honoŕe, T., Drejer, J., Glutamate-induced increase in intracellular Ca2 + in cerebral cortex neurons is transient in immature cells but permanent in mature cells. J. Neurochem. 53 (1989), 1316–1319.
34. Kuhlmann, C.R., Zehendner, C.M., Gerigk, M., Closhen, D., Bender, B., Friedl, P., Luhmann, H.J., MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion. Neurosci. Lett. 449 (2009), 168–172.